Zydus lifesciences said that US Food and Drug Administration (USFDA) classified the inspection conducted at its injectables manufacturing facility located at Ahmedabad in March 2024 as OAI (Official Action Indicated). Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
